×
About 425 results

ALLMedicine™ Status Asthmaticus Center

Research & Reviews  128 results

Pneumomediastinum Workup
https://emedicine.medscape.com/article/1003409-workup

May 19th, 2022 - Laboratory Studies The following studies are indicated in suspected cases of pneumomediastinum (PM): ABG ABG should be checked in individuals presenting with respiratory distress. Depending on the severity of the underlying respiratory compromise,...

Endotracheal Tube Size Is Associated With Mortality in Patients With Status Asthmaticus.
https://doi.org/10.4187/respcare.09609
Respiratory Care; Kashiouris MG, Chou CD et. al.

Feb 23rd, 2022 - There is limited evidence on the clinical importance of the endotracheal tube (ETT) size selection in patients with status asthmaticus who require invasive mechanical ventilation. We set out to explore the clinical outcomes of different ETT intern...

Endotracheal Tube Size Is Associated With Mortality in Status Asthmaticus: A Confirmati...
https://doi.org/10.4187/respcare.09946
Respiratory Care; Gilmore TW

Feb 23rd, 2022 - Endotracheal Tube Size Is Associated With Mortality in Status Asthmaticus: A Confirmation of the Suspicion?|2022|Gilmore TW,|

A pediatric hospital-wide asthma severity score: Reliability and effectiveness.
https://doi.org/10.1002/ppul.25861
Pediatric Pulmonology; McBride SC, McCarty K et. al.

Feb 20th, 2022 - Asthma is a leading cause of pediatric hospitalization in the United States. Children hospitalized with asthma are often managed in different care settings during hospitalization, posing challenges to accurate communication among care providers ab...

Hypokalemia Measurement and Management in Patients With Status Asthmaticus on Continuou...
https://doi.org/10.1542/hpeds.2021-006265
Hospital Pediatrics; Cox C, Patel K et. al.

Jan 13th, 2022 - Status asthmaticus is commonly treated in pediatric patients by using continuous albuterol, which can cause hypokalemia. The primary aim of this study was to determine if serial potassium monitoring is necessary by examining treatment frequency of...

see more →

Guidelines  1 results

Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critical...
https://doi.org/10.1097/CCM.0000000000002027
Critical Care Medicine; Murray MJ, DeBlock H et. al.

Oct 19th, 2016 - To update the 2002 version of "Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient." A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of n...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  4 results

Evaluatıng The Effects Of Web Desıgn In Educatıng Asthma Patıents On Drug Complıance And Qualıty Of Lıfe
https://clinicaltrials.gov/ct2/show/NCT04607681

Dec 7th, 2021 - In the first stage, it is aimed to develop, implement and evaluate a web designed asthma education program for asthma patients. In the second stage, it is to evaluate the effect of the web-designed education program developed for asthmatic patient...

High Flow Nasal Cannula in Children With Status Asthmaticus
https://clinicaltrials.gov/ct2/show/NCT03157102

Apr 29th, 2021 - In France, over 2.5 million people suffer from asthma, including one-third of children. This is the chronic respiratory disease leading to the highest rate of hospitalization. The conventional oxygen delivery means in children are the non-rebreath...

Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
https://clinicaltrials.gov/ct2/show/NCT01188473

Dec 19th, 2014 - Status asthmaticus is defined as severe asthma that fails to respond to inhaled short acting β agonists (SABA), oral or intravenous steroids, and oxygen, leading to hospital admission for further management (1). In 2004, asthma exacerbations led t...

Evaluation Montelukast in the Treatment of Status Asthmaticus
https://clinicaltrials.gov/ct2/show/NCT01770899

Feb 25th, 2013 - While new medications have been used to better manage chronic asthma, acute exacerbations continue to be a significant cause of pediatric morbidity and mortality. Montelukast holds an established role in the pediatric outpatient management of asth...

see more →

News  23 results

FDA OKs First-in-Class Biologic for Severe Asthma
https://www.medpagetoday.com/allergyimmunology/asthma/96288

Dec 20th, 2021 - The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenanc...

Extracorporeal CO2 Removal Effective in Status Asthmaticus
https://www.staging.medscape.com/viewarticle/939594

Oct 23rd, 2020 - NEW YORK (Reuters Health) - Venovenous extracorporeal carbon dioxide removal (ECCO2R) may be lifesaving in patients with status asthmaticus refractory to maximal medical therapy, according to a retrospective review. In a paper in Critical Care Med...

FDA approves benralizumab autoinjector for eosinophilic asthma
https://www.mdedge.com/pulmonary-health-hub/article/209478/asthma/fda-approves-benralizumab-autoinjector-eosinophilic?channel=94
Christopher Palmer

Oct 4th, 2019 - The Food and Drug Administration has approved a prefilled, single-use autoinjector of benralizumab (Fasenra) for self-administration in adults with eosinophilic asthma, according to a press release from AstraZeneca. Benralizumab is already approve.

Refractory Status Asthmaticus: Treatment With Sevoflurane
https://www.mdedge.com/fedprac/article/209328/hospital-medicine/refractory-status-asthmaticus-treatment-sevoflurane/page/0/1?channel=327

Oct 3rd, 2019 - Discussion This case illustrates the successful treatment of a patient with extreme status asthmaticus given inhalational anesthesia as supportive care while the bronchospasm and status asthmaticus abated. This is an unusual treatment in an ominou.

FDA OKs Asthma Inhaler Arnuity Ellipta for Kids as Young as 5 Years
https://www.medscape.com/viewarticle/897049

May 22nd, 2018 - The US Food and Drug Administration (FDA) has expanded the use of the inhaled corticosteroid fluticasone furoate (Arnuity Ellipta, GlaxoSmithKline) as a once-daily asthma maintenance treatment for children as young as age 5 years. "Despite the cha...

see more →